Covid-19 roundup: Pfiz­er/BioN­Tech launch Omi­cron-spe­cif­ic vac­cine tri­al; UK to re­cruit thou­sands more for mol­nupi­ravir study

Pfiz­er and BioN­Tech an­nounced Tues­day that they’ve ini­ti­at­ed a clin­i­cal study to eval­u­ate the safe­ty, tol­er­a­bil­i­ty and im­muno­genic­i­ty of an Omi­cron-tar­get­ed vac­cine can­di­date in healthy …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER